Lead Product(s) : 2-Hydroxyoleic Acid,Temozolomide
Therapeutic Area : Oncology
Study Phase : Phase II/ Phase III
Sponsor : Not Applicable
Deal Size : Not Applicable
Deal Type : Not Applicable
Laminar Completes Recruitment for LAM561 in Glioblastoma Trial
Details : LAM561 (2-hydroxyoleic acid) is an oral synthetic derivative of oleic. It is being evaluated in combination with TMZ & RT for the treatment of glioblastoma.
Brand Name : LAM561
Molecule Type : Small molecule
Upfront Cash : Not Applicable
June 11, 2024
Lead Product(s) : 2-Hydroxyoleic Acid,Temozolomide
Therapeutic Area : Oncology
Highest Development Status : Phase II/ Phase III
Sponsor : Not Applicable
Deal Size : Not Applicable
Deal Type : Not Applicable
LOOKING FOR A SUPPLIER?